Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, July 28, 2017
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
Thu, July 27, 2017
[ Thu, Jul 27th 2017
] - WOPRAI
[ Thu, Jul 27th 2017
] - WOPRAI
[ Thu, Jul 27th 2017
] - WOPRAI
[ Thu, Jul 27th 2017
] - WOPRAI
[ Thu, Jul 27th 2017
] - WOPRAI
[ Thu, Jul 27th 2017
] - WOPRAI
Vincent Chen Initiated (BLUE) at Hold and Held Target at $109 on, Jul 27th, 2017
Published on 2024-10-25 21:56:47 -
Vincent Chen of Bernstein, Initiated "bluebird bio, Inc." (BLUE) at Hold and Held Target at $109 on, Jul 27th, 2017.
Vincent has made no other calls on BLUE in the last 4 months.
There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 2 agree with Vincent's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $103 on, Monday, July 10th, 2017
- Dane Leone of "BTIG" Downgraded from Strong Buy to Hold on, Friday, June 30th, 2017
This is the rating of the analyst that currently disagrees with Vincent
- Matthew Luchini of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $108 on, Tuesday, June 6th, 2017